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Mechanical thrombectomy (MT) is a breakthrough in the treatment of acute ischaemic stroke (AIS) 
caused by a large artery occlusion (LAO), 
and has been shown to be much more 
effective than intravenous thrombolysis 
(IVT) for this subgroup of stroke. Even 
with IVT, only a quarter of this group 
of patients with acute stroke survive 
without major disability. The evidence 
base for MT for anterior-circulation LAO 
stroke is clear, with eight randomised 
controlled trials demonstrating 
substantial benefits over best medical 
therapy in patients presenting early after 
stroke,1 and high-quality evidence for 
benefit emerging in carefully selected, 
patients presenting after 6 hours.2,3 
National and international stroke 
guidelines, including those published 
by NICE,4 recognise MT as standard 
treatment, and progress has been made 
in terms of a national commissioning 
policy for MT from NHS England, which 
supports the routine commissioning 
of MT for LAO AIS.5 The NHS Long 
Term Plan agrees with the efficacy 
of MT.6 MT for LAO AIS may also 
be associated with cost savings: on 
average, each patient treated with MT 
would save the NHS and social services 
more than £35,000 over 5 years.7 
However, there are still significant 
challenges in rolling out this service 
across the UK. Approximately 1100 MT 
procedures were performed in England 
in 2018–19, representing only 1.4% 
of all cases of AIS;8 Northern Ireland 
currently provides MT to around 3% 
of stroke admissions, few procedures 
are performed in Wales, and Scotland 
currently has no MT services. The 
NHS Long Term Plan aims for an 
increase in this figure to around 8000 
MT procedures in England by 2022, 
recognising that 1600 more people 
every year would be independent 
after their stroke as a result;6 however, 
given that some parts of the UK are 
still virtually devoid of an MT service, 
a concerted effort to deliver this 
treatment from all agencies and 
disciplines involved in stroke care will 
be needed.
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This article outlines the key 
considerations when introducing an 
MT service, focusing on the most 
significant changes—reconfiguration 
of hyperacute stroke, ambulance, 
and imaging services—and offering 
practical recommendations for 
stroke service reorganisation and 
development of a business case. 
Lessons learned from the earlier 
implementation of IVT, primary 
percutaneous coronary intervention 
(PPCI) for ST elevation myocardial 
infarction, and centralisation of acute 
stroke services are also considered.
Reconfiguring hyperacute 
stroke services 
Hyperacute stroke services are 
conventionally divided between 
comprehensive stroke centres (CSCs), 
which are both IVT- and MT-capable, 
and primary stroke centres (PSCs), 
which deliver IVT but depend on 
secondary transfer to a CSC for 
MT treatment. Hyperacute stroke 
care may be delivered through two 
models. In the ‘mothership’ model, 
all patients with suspected stroke 
are taken directly to a CSC, possibly 
bypassing a nearer PSC, which results 
in greater onset-to-treatment times 
for IVT for some patients but removes 
the need for secondary transfer by 
road ambulance or helicopter. In the 
‘drip-and-ship’ model, local IVT may 
be delivered at PSCs before patients 
with AIS eligible for MT are transferred 
to the CSC. The choice of approach 
depends on geography and travel times, 
availability of appropriately skilled staff, 
urban/rural split, and other factors, 
including the maximum practical 
size of a CSC under a mothership 
configuration and the minimum 
recommended size of a PSC in a 
drip-and-ship model.
To maintain the recommended 
minimum 600 admissions to any 
hyperacute stroke unit, the number 
of acute admitting centres in the 
UK will need to be reduced—for 
example, the modelled maximum 
number of PSCs and CSCs combined 
in England would need to be about 
80, whereas the maximum number of 
MT-capable CSCs treating a minimum 
of 150 patients would be 40.9 Time 
to MT is reduced if patients directly 
attend a CSC, even if that involves 
travelling further than the nearest 
PSC; however, such decisions applied 
universally jeopardise the sustainability 
of networks by overloading CSCs and 
reducing admissions to many PSCs to 
unsustainably low levels.9 Modelling 
has shown that planning at a regional 
or national level is needed when 
significant reconfiguration of services 
for both IVT and MT is required if 
the benefits are to be optimised, 
because planning at sustainability and 
transformation partnership level is 
likely to lead to suboptimal service 
organisation for patients.10
Ambulance services
Approximately half of patients with 
suspected stroke who present to 
ambulance services have a final 
diagnosis of a stroke mimic, meaning 
that fewer than one in 10 are likely 
to meet the clinical and radiological 
characteristics appropriate for MT. 
Ideally, these patients should be 
identified early and rapidly transported 
to a CSC to reduce time to treatment. 
Although centralisation of stroke care 
already requires ambulance services 
to provide pathways promoting rapid 
access to specialist care in line with 
national clinical guidelines,11 the main 
immediate impact of MT provision 
for ambulance services will be further 
centralisation of specialist care for 
a small proportion of patients with 
major stroke.
Stroke pathways within ambulance 
services in the UK vary considerably, 
and regions expanding MT provision will 
need to consider whether differences 
may impact on efficient direct transfers 
for treatment. Ambulance services 
and commissioners must be involved 
early in the planning of acute stroke 
pathways, including repatriation 
pathways. Services must plan to deal 
with the resource implications of an 
increasing number of MT secondary 
drip-and-ship transfers. A coordinated 
network approach will be needed.
Radiology
Emergency vascular imaging of LAO 
stroke is critical for the selection 
of appropriate patients for onward 
referral to MT. Computed tomography 
(CT) is the basis of most emergency 
neuroimaging for suspected stroke 
in the UK, and is preferred to the 
alternative magnetic resonance 
imaging for reasons such as speed 
and ease of access. For the selection 
of patients suitable for MT, a 
combination of non-contrast computed 
tomography—a well-established 
standard imaging modality for 
stroke prior to IVT—and computed 
tomography angiography (CTA) is most 
appropriate. The relatively low levels of 
MT currently being performed in the 
UK are, in part, due to lack of routine 
use of CTA in local stroke imaging 
protocols. Universal implementation of 
CTA in all hospitals receiving patients 
with suspected acute stroke therefore 
represents the first phase in forming 
effective acute stroke MT networks 
across the UK. Because most initial 
stroke imaging will be performed 
in non-neuroscience centres, this is 
where the largest expansion in the 
provision of acute stroke imaging will be 
needed, requiring new equipment, new 
software, and training of radiologists 
and stroke physicians to interpret CTA 
or use appropriately validated artificial 
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intelligence (AI) software for immediate 
CTA decision support. Because MT 
provision extends to 24-7 coverage, 
around-the-clock imaging interpretation/
support will be needed to facilitate 
clinical decision making, and it may be 
necessary to use outsourced emergency 
radiology reporting and validated AI 
software where local radiology services 
are not available out of hours.
The lessons of past 
experience
Thrombectomy is not the first 
high-value treatment to require 
major service reconfigurations, 
and it is helpful to reflect on the 
implementation of other disruptive 
innovations to learn what does and 
does not work. Boxes 1–312–17 review the 
service reconfigurations required for 
PPCI for myocardial infarction, IVT, and 
centralisation of acute stroke services, 
respectively, highlighting the key 
lessons learned.
Three 24-7 MT services are already 
running successfully in England, 
and their experiences are helpful 
to illustrate the challenges, pitfalls, 
and drivers needed to adapt existing 
stroke services to deliver MT to 
eligible patients. For example, the 
first commissioned 24-7 MT service 
was established in the University 
Hospitals of North Midlands NHS 
Trust (then North Staffordshire NHS 
Trust) in January 2010, and has since 
treated more than 500 patients.12 This 
required redesign of acute stroke 
treatment pathways within the trust 
and across the region. Communication 
was key throughout, and the service 
could not have worked without the 
cooperation of many specialties. The 
current challenges for successful 
implementation of an MT service are 
related to workforce limitations and 
the adoption of a functioning network 
approach to the service by CSCs and 
their referring PSCs. NHS England’s 
initiative in establishing integrated 
stroke delivery networks (ISDNs) is 
critical to the success of delivering 
equitable care. Developing a robust 
business case for provider trusts is also 
essential. Box 4 summarises the key 
learnings from the development of the 
North Midlands service.
Box 1: Key lessons from the implementation of PPCI for STEMI
Much like MT, PPCI for STEMI was a ground-breaking treatment that required 
massive changes to infrastructure and service provision. Strong support from the 
DH and professional societies was required for the implementation of PPCI as the 
new standard of care for STEMI to gain traction, with national leads tasked with 
facilitating implementation. Despite the challenges and barriers, an increase from 
39% of eligible patients treated with PPCI to 90% was achieved within just 3 years 
between 2008 and 2011,12 and PPCI is now the default treatment for STEMI.
Key lessons from this experience were:
 • co-ordinated regional networks were critical to the implementation of 
reconfigured services
 • all centres offering a new emergency interventional treatment should have a plan 
that ensures that patients will be able to access this treatment on a 24-7 basis, 
365 days a year, within a finite time period (e.g. 2 years)
 • regular communications and meetings allow newer centres to quickly move up 
the learning curve and adopt best practice
 • continuous data monitoring of the process and outcome measures is essential to 
demonstrate that treatment is benefitting patients and providing cost-effective care.
MT=mechanical thrombectomy; PPCI=primary percutaneous coronary intervention; STEMI=ST 
elevation myocardial infarction
Box 2: Key lessons from the implementation of IVT
Although some UK sites participated in previous trials of IVT for AIS in the 1990s, 
NHS services and the DH had no plan or strategy for the implementation of an acute 
stroke therapy once alteplase was licenced in 2003. Thrombolysis was a disruptive 
innovation that was challenging to incorporate into existing care pathways for 
stroke, and there was resistance to the shift to a 24-7 service capable of delivering 
IVT that meant progress was slow until the National Stroke Strategy prioritised 
implementation from 2007 onwards. It was not until 17 years after the publication 
of the pivotal alteplase study that all hospitals in England that receive acute stroke 
patients were delivering IVT and around 12% of all ischaemic stroke admissions were 
receiving alteplase.12
Key lessons from the experience with IVT were:
 • regional clinical networks provided clinical leadership and managerial support 
and were key to the development of local implementation plans and sharing best 
practice to deliver IVT
 • working with ambulance services and emergency department teams was critical to 
improving recognition of stroke and expediting the emergency response
 • protocol-driven access to urgent brain CT was critical to reducing door-to-needle 
time for IVT
 • development of teams to deliver around-the-clock IVT services required multiple 
specialties to support on-call rotas
 • in some large metropolitan areas, rates of IVT did not improve until services 
were centralised.
AIS=acute ischaemic stroke; CT=computed tomography; IVT=intravenous thrombolysis
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Summary
MT for AIS represents a 
once-in-a-generation opportunity 
to alter the miserable prognosis 
for the most devastating form of 
stroke, with substantial benefits for 
individuals and for wider health and 
social care. Such a step change in 
treatment for many people with major 
disabling stroke requires considerable 
infrastructure to deliver, and will 
involve further centralisation of 
services for hyperacute stroke. The 
NHS Long Term Plan’s objective of 
a 10% increase in MT in England by 
20226 is commendable, but previous 
centralisations in the UK have been 
limited to a small number of mainly 
metropolitan areas, with others 
proving very slow to progress. 
National implementation of MT for 
stroke requires the resources and 
leadership that were necessary to 
implement similar innovations in 
the recent past, working within new 
collaborative ISDNs. The opportunity 
to make thrombectomy a routine 
option for the treatment of eligible 
patients with stroke across the UK 
requires visionary and concerted 
input from all agencies and disciplines 
involved in stroke care, but the 
game-changing outcomes for patients 
eligible for this treatment will certainly 
be worth that effort.
Mechanical thrombectomy 
for acute ischaemic stroke: an 
implementation guide for the UK 
can be freely downloaded from: 
www.oxfordahsn.org/our-work/
adopting-innovation/mt-guide/
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Box 4: Key lessons from existing MT service reconfigurations
 • Setting up a 24-7 service requires a change of institutional mindset
 • Many issues with establishing the service can be overcome through collaborative 
working within a regional network
 • Necessary infrastructure must be planned, including access to biplane 
neuroangiography equipment and sufficient HASU capacity at the CSC to manage 
patients transferred from other hospitals 
 • A clear idea of total costs and how many thrombectomies are required to deliver a 
financially sustainable service is crucial
 • Coordination with ambulance services is essential
 • Staff across the care pathway, including those who interpret CTA and assess 
patient suitability in referring PSCs, must be trained with the new skills to identify 
and select appropriate patients
 • High-quality, post-MT procedure care is essential to achieve successful patient 
outcomes
 • Appropriate system governance is required to review outcomes and feedback 
results and timings to referrers to ensure the pathway is safe and efficient.
CSC=comprehensive stroke centre; CTA=computed tomography angiography; HASU=hyperacute 
stroke unit; MT=mechanical thrombectomy; PSC=primary stroke centre
Key points
 • MT for AIS represents a once-in-a-generation opportunity to alter the miserable 
prognosis for the most devastating form of stroke, with substantial benefits for 
individuals and for wider health and social care
 • Such a step change in treatment for many people with major disabling stroke 
requires considerable infrastructure to deliver, and will involve further 
centralisation of services for hyperacute stroke
 • The most significant changes will be reconfiguration of hyperacute stroke services, 
ambulance services, and neuroimaging 
 • National implementation of MT for stroke as a routine option for the treatment of 
eligible patients with stroke across the UK requires visionary and concerted input 
from all agencies and disciplines involved in stroke care.
